Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study.

However, in males, in individuals aged ≥ 75, in those with eGFR ≥ 45 mL/min/1.73 m 2 , and in those with a history of gout, the association was attenuated and did not reach statistical significance for the secondary outcome of all‐cause death.

also in 111,027 other papers